Skip to main content
Premium Trial:

Request an Annual Quote

Celera Finally Gets Drug R&D Head; Waterston to Head U. Wash Genomics Department; and Others

NEW YORK, July 10 - The University of Nevada, Reno said today it has hired Martin Gollery to be the associate director of bioinformatics.

 

Gollery sits on the scientific advisory boards of TimeLogic and Infoceutics.

 


 

The University of Washington School of Medicine, Seattle chose Robert Waterston to chair its department of genome sciences, the school's dean said yesterday.

 

Waterston, who is expected to start at the school in January, already heads the department of genetics as well as the Genome Sequencing Center at the Washington University School of Medicine, St. Louis.

 


 

Biogen said yesterday it has named Christine Carberry vice president of program and alliance management.

Carberry was formerly Biogen's program executive of the LFA-1 program, which focuses on the development of T-cell migration and activation inhibitors.

 


 

Celera Genomics has tapped Robert Booth senior vice president of research and development, the company said on Monday.

 

Booth, who starts on Aug. 5, comes to the nascent drug developer from Hoffman-La Roche, where he was senior vice president of the inflammatory- and viral-diseases business unit.

 


 

Hyseq has made Nina Giles vice president of business development.

 

Giles joins the company from Incyte Genomics, where she most recently was vice president of business development.

 



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at
[email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.